Haematological manifestations of COVID-19: From cytopenia to coagulopathy
- PMID: 32663356
- PMCID: PMC7404736
- DOI: 10.1111/ejh.13491
Haematological manifestations of COVID-19: From cytopenia to coagulopathy
Abstract
Emerging data from the management of patients with coronavirus disease 2019 (COVID-19) suggests multi-systemic involvement, including the hemopoietic system. The haematological manifestations of COVID-19 include blood count anomalies notably lymphopenia and neutrophilia which are of prognostic significance. Hyperferritinemia and elevated lactate dehydrogenase have also been associated with increased mortality. Furthermore, there is considerable evidence of a distinct coagulopathy associated with COVID-19 characterised by elevated D-dimers and an increased risk of thrombotic events. This comprehensive review summarises the latest evidence from published studies and discusses the implications of the various haematological manifestations of COVID-19 with a view to guiding clinical management and risk stratification in this rapidly evolving pandemic.
Keywords: COVID-19; D-dimer; SARS-CoV-2; blood count; coagulopathy; cytokine storm; lymphopenia.
© 2020 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interests in relation to this article.
Figures
References
-
- COVID‐19 Map – Johns Hopkins Coronavirus Resource Center. n.d. https://coronavirus.jhu.edu/map.html. Accessed April 25, 2020.
-
- World Health Organization . Modes of transmission of virus causing COVID‐19: implications for IPC precaution recommendations 2020. https://www.who.int/publications‐detail/modes‐of‐transmission‐of‐virus‐c.... Accessed May 11, 2020
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous